Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery

Last updated: October 31, 2018
Sponsor: Maastricht University Medical Center
Overall Status: Completed

Phase

3

Condition

Dysmenorrhea (Painful Periods)

Colic

Lactose Intolerance

Treatment

N/A

Clinical Study ID

NCT02716285
NL56000.068.16; METC162009
2015-005467-16
  • Ages 18-75
  • All Genders

Study Summary

Peppermint oil has shown to be effective in the treatment of Irritable Bowel Syndrome (IBS) symptoms in several meta-analyses. However, the level of evidence is moderate and peppermint oil remains relatively under-used in IBS. Therefore, the investigators will conduct a multicenter randomized, placebo controlled trial to investigate the effects of an eight-week peppermint oil treatment in IBS patients according to current European Medicines Agency (EMA) / US Food and Drug Administration (FDA) guidelines. To improve efficacy and to reduce side effects, the investigators aim to study the use of a new peppermint oil formulation, a colon-targeted-delivery capsule that will release the oil in the (ileo-) colonic region specifically.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age between 18 and 75 years;

  2. Diagnosed with Irritable Bowel Syndrome according to the Rome IV criteria:

(Recurrent abdominal pain, at least 1 day/week for the last 3 months; Symptom onset atleast 6 months prior to diagnosis; Associated with two or more of the following:

  1. Pain related to defecation;

  2. Pain associated with a change in frequency of stool;

  3. Pain associated with a change in form (appearance/consistency) of stool

  4. Based on the medical history and previous examination, no other causes for theabdominal complaints can be defined. Especially no history of:

  5. Inflammatory Bowel Disease;

  6. Celiac Disease;

  7. Thyroid dysfunction (if not well-regulated). If alarm symptoms (includingunexplained rectal blood loss or weight loss) are present, a colonoscopy has beenperformed and was negative for other causes.

  8. Women in fertile age (<55 years old) must use contraception or be postmenopausal forat least two years.

  9. Average worst abdominal pain score (on 11-point NRS) of > 3, during the two-weekrun-in period.

Exclusion

Exclusion Criteria:

  1. Insufficient fluency of the Dutch language;

  2. Any previous use (also incidental use) of peppermint oil capsules in the last 3 monthsprior to inclusion (the use of peppermint tea, menthol candy etc. is allowed);

  3. The inability to stop regular use of medication affecting the gastro-intestinal system (such as Non Steroidal Anti Inflammatory Drugs (NSAID), laxatives, prokinetics,opioids, smasmolytics and anti-diarrhoeal drugs). This use should be halted at least 1week before enrollment into the run-in period;

  4. The use of 1 antidepressant drug is allowed, providing dosing has been stable for > 6 weeks before enrollment;

  5. The use of 1 proton pump inhibitor (PPI) is allowed, providing dosing has beenstable > 6 weeks before enrollment;

  6. Previous major abdominal surgery or radiotherapy interfering with gastrointestinalfunction:

  7. Uncomplicated appendectomy, cholecystectomy and hysterectomy allowed unlesswithin the past 6 months;

  8. Other surgery upon judgment of the principle investigator;

  9. History of liver disease, cholangitis, achlorhydria, gallstones or other diseases ofthe gallbladder/biliary system;

  10. Pregnancy, lactation;

  11. Using drugs of abuse;

  12. Known allergic reaction to peppermint.

Study Design

Total Participants: 190
Study Start date:
August 17, 2016
Estimated Completion Date:
October 01, 2018

Connect with a study center

  • Medical Center Leeuwarden

    Leeuwarden, Friesland 8934 AD
    Netherlands

    Site Not Available

  • Gelderse Vallei Hospital

    Ede, Gelderland 6716 RP
    Netherlands

    Site Not Available

  • Alrijne Hospital

    Leiden, Zuid Holland 2334 CK
    Netherlands

    Site Not Available

  • Maastricht University Medical Center

    Maastricht, 6229 ER
    Netherlands

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.